Lupin Limited has informed the Exchange regarding a press release dated March 27, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Valbenazine Capsules.".
Lupin Limited has informed the Exchange regarding a press release dated March 27, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Valbenazine Capsules.".